We only have this paper's title and publication details.
Read it at the sourceThis case report reveals a unique unilateral mosaic pattern of cutaneous immune-related adverse events from pembrolizumab, indicating a distinct response mechanism.
No takes yet. Share an insight, caveat, or question.
Takamoto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: